AMENDMENT No.1License Agreement • October 30th, 2015 • Vical Inc • Biological products, (no disgnostic substances)
Contract Type FiledOctober 30th, 2015 Company IndustryThis Amendment No.1 (the “Amendment”), dated as of 31st of August 2015, is by and between Vical Incorporated, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and Astellas Pharma Inc., a company organized under the laws of Japan (“Astellas”), having an address of 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan.